THE United States was on the verge of making a controversial amendment to the US patent law in June this year that would have modelled it on India's Patent Law which prohibits the patenting of new...

CHEMICALS and biotech company Lonza Group will purchase a sterile drug product fill-and-finish facility in Stein, Switzerland, from Novartis.

[HONG KONG] A deadly fungus that is spreading across the globe is sending Chinese pharma stocks surging.

[NEW YORK] Johnson & Johnson raised US prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner...

[HONG KONG] There may be such a thing as a free lunch in China's pharmaceutical industry. It turns out it's not an unlimited buffet, though.

[LONDON] European companies aren't alone in their Brexit pain. Pfizer Inc., the US-based drug behemoth, says its costs for dealing with the upcoming split will reach US$100 million.